Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.


CHMP backs AZ's 'superbug' antibiotic product

CHMP backs AZ's 'superbug' antibiotic product In the US, Actavis (now operating as Allergan) has been granted FDA approval for another combination of ceftazidime and avibactam, which is sold as Avycaz. ... Actavis gained rights to the combination after buying Forest Labs, which originally developed

US tax changes claim Pfizer scalp as Allergan deal abandoned

US tax changes claim Pfizer scalp as Allergan deal abandoned So for Allergan - formerly known as Actavis, its acquisitions of Warner Chilcott in 2013, Forest Laboratories in 2014 and Allergan in 2015 that turned it into a $109bn company would be

Size matters?

Size matters? It merged with Actavis in March in a $70.5bn deal and then reached an agreement to sell its generics business to Teva for $40.5bn The Teva deal, due to

UK court backs Actavis in dispute over Lilly's Alimta

UK court backs Actavis in dispute over Lilly's Alimta drug's side effects - is not infringed by a generic version of the drug sold by Allergan's Actavis unit. ... patent would not be infringed by yet another salt - Actavis' pemetrexed dipotassium - after the December 2015 compound patent expiration.

UK government fines GSK over 'pay-for-delay' deals

UK government fines GSK over 'pay-for-delay' deals Merck KGaA and Actavis also fined for their involvement. The UK's Competition &Markets Authority has fined GlaxoSmithKline (GSK) and several other companies for delaying the availability of generic versions of ... Actavis which have both been fined for

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...